Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fufang Shenyan Tablet in IgA nephropathy
ChiCTR-TRC-10000824Phase 4Completed
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Fufang Shenyan in IgA nephropathy (IgAN) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: 24-hour urinary protein, Renal function and 1 more. Started Jan 2010; status: completed.
02
Drugs
Fufang Shenyan
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-TRC-10000824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000824.